Drugs / TADIOS
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT05552625 Comparator | May 2021 → Feb 2022 | COVID-19 | Helixmith Co., Ltd. | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TADIOS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05552625 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “TADIOS is a combination extract which composed of three herbs, and each herbal medicine has been traditionally used as a food or a herbal medicine treating various respiratory...” NCT05552625 ↗ |